CFTR and cystic fibrosis: We tested the published 5-year predicted survival model of CF derived from a 1993–1997 US cohort of patients using new cohorts because new treatments (including CFTR modulators for 2005–2010 and 2011–2016 cohorts) improved observed mortality rates.